Delivery Order SPE2DB24D3013-SPE2DB25FFLTE
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,164.42, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and the ultimate completion date...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,504.50, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a medication, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. The contract has an ultimate...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,367.21 firm fixed-price contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The award has a performance period ending on May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set-aside. The company holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, with a ceiling value of $2,254.24 and a completion date of February 7, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract has a potential value of $56,760.00 and a performance period through January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designation. In addition to this specific...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a prescription medication, with a ceiling value of $6,080.20 and a performance period ending on May 16, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The award, valued at $7,756.47, has an ultimate completion date of August 14, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides for the delivery of a comprehensive range of medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The award is for the supply of Atovaquone-Proguanil 250-100 100s, a brand name pharmaceutical product, in support of military treatment programs and facilities. The order has a ceiling value of $17,356.88 and a period of performance through April 5, 2024. This delivery order is issued under an indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product. The contract has a ceiling value of $1,528.92 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, with no set-aside designation used. This award is...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The award, valued at $5,586.93, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...